The news today leads off with the announcement by New Jersey based firm Synergy Research of its Patient Registry Services. It’s goal: to help the pharmaceutical and medical device industries design and implement patient registry programs. These Registry programs help provide real-world data on a product's safety and/or effectiveness. Registries can address pre- or post- approval regulatory requirements, for US or foreign development programs. Drug manufacturers are increasingly dependent on the real world performance of their products, and Synergy is there with a host of services to fill those needs. With cutting edge data collecting capabilities, Synergy has the expertise and resources to manage patient registry programs of any size from start to finish. Pharmaceutical firms need post approval studies from larger and more diverse populations than what is normally obtained from clinical trials. A patient registry program from Synergy can help accelerate innovation, improve company focus and alert it to new opportunities or potential problems with a product. And in today’s rapidly shifting marketplace these are big advantages that any firm can use. Usable, high-quality knowledge of your company’s health products; understanding real world disease and treatment courses, patient-reported outcomes, dynamic expanded product safety, effectiveness, and use patterns, risk minimization programs, as well as cultivating positive relationships with clinicians, and establishing leadership branding. Synergy stands ready to supply you with today’s real world data to ensure tomorrow’s real world outcomes.